NCT06089421 Genetic Information Assistant in Telegenetics
| NCT ID | NCT06089421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Virginia |
| Condition | Gene Mutation-Related Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2025-04-01 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about different ways cancer genetic screening can be provided to rural communities in participants at high risk for certain cancers. The main question it aims to answer is: • Does receiving pre-genetic test education with a chat bot or genetic counselor affect if the participant decides to get genetic testing? Participants will: * have a pre-test genetic counselling session with a genetic counselor or the GIA chatbot * answer questions about their cancer genetic knowledge and how they are doing * provide a saliva sample for genetic testing to test for cancer gene mutations * have their genetic testing results provided to them. * have the option to share their genetic testing results with family members Researchers will compare how many participants who had pre-genetic counseling with the chatbot received genetic testing to how many participants who had pre-genetic counseling with a genetic counselor received genetic testing.
Eligibility Criteria
Inclusion Criteria: * At high risk for having a genetic pathogenic variant as assessed by a GC or physician according to the NCCN guidelines * Provision of signed and dated informed consent form. * Stated willingness to comply with all study procedures and availability for the duration of the study. * Male or female, aged 18 and over. * Subjects must have a smartphone with access to cellular and/or internet service or a computer with internet service. * Subjects must have technological competency/proficiency to use their Smartphone and/or computer in conjunction with the communication aid GIA. Exclusion Criteria: * Cannot communicate in English or Spanish. * Subjects must not have completed panel-based cancer genetic testing in the past.
Contact & Investigator
Kari Ring, MD
PRINCIPAL INVESTIGATOR
University of Virginia
Frequently Asked Questions
Who can join the NCT06089421 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gene Mutation-Related Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06089421 currently recruiting?
Yes, NCT06089421 is actively recruiting participants. Contact the research team at EV4PD@uvahealth.org for enrollment information.
Where is the NCT06089421 trial being conducted?
This trial is being conducted at Charlottesville, United States.
Who is sponsoring the NCT06089421 clinical trial?
NCT06089421 is sponsored by University of Virginia. The principal investigator is Kari Ring, MD at University of Virginia. The trial plans to enroll 96 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.